Skip to main content
. 2019 Oct 7;9:14394. doi: 10.1038/s41598-019-50840-7

Figure 4.

Figure 4

Effect of pan-HSPA inhibitors on cell viability and HSPAs expression in NSCLC cells. (A,C) Dose-response curves of VER-155008 (VER) (A) and JG-98 (C) in NSCLC cells. Cell viability was measured following 72 h treatment with VER (0–50 µM) or JG-98 (0–5 µM) using MTS assay. Results (mean ± SD from at least three independent measurements, each in three technical repeats) are expressed relatively to untreated control. (B,D) Expression of HSPA1, HSPA2, HSPA5, HSPA8 and HSPC proteins in NSCLC cell lines following 24 h treatment with VER or JG-98. Representative immunoblots are shown (n ≥ 3), actin was used as a protein loading control.